CD8A and cancer: In breast cancer patients (24) and a mouse lymphoma model (25), dormant DTCs have been observed to persist in the bone marrow along with a rise in CD4+ and CD8+ T cells, indicating that in addition to CD8+ T cells, CD4+ T cells also played a role in cancer dormancy.